Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details
Close

Aslan Pharmaceuticals Ltd ADR (ASLN)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Aslan Pharma ADR's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.943 +0.038    +4.23%
16:00:04 - Closed. Currency in USD ( Disclaimer )
After Hours
0.943
0.000
0.011%
18:58:12 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 226,200
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 0.911 - 0.950
Aslan Pharma ADR 0.943 +0.038 +4.23%
InvestingPro Earnings Insights
Latest Release

Aug 12, 2022

EPS / Forecast

-0.04 / -0.2

Revenue / Forecast

0.00 / 0.00

Revenue
EPS
 Forecast
 
Release Date Period End EPS /  Forecast Revenue /  Forecast
Nov 03, 2022 09/2022 -- /  -0.19 -- /  0.00
Aug 12, 2022 06/2022 -0.04 /  -0.2 0.00 /  0.00
Apr 27, 2022 03/2022 -0.19 /  -0.18 0.00 /  0.00
Mar 25, 2022 12/2021 -0.16 /  -0.14 0.00 /  0.00
Oct 26, 2021 09/2021 -0.12 /  -0.1233 0.00 /  0.00
Aug 06, 2021 06/2021 -0.08 /  -0.11 0.00 /  0.00
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View upcoming earnings forecasts and in-depth analysis of company forecasts.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ASLN Comments

Write your thoughts about Aslan Pharmaceuticals Ltd ADR
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
apka Trader
apka Trader Mar 04, 2021 7:26AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
any idea to hold or sale
Sultan Sa
Sultan Sa Mar 04, 2021 7:26AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Hold
Piter Max
Piter Max Mar 01, 2021 12:46PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
why is down from 8 to 5.50?
Mohammad Nofal
Mohammad Nofal Mar 01, 2021 8:24AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
10 my dear
Amaury Delard
Amaury Delard Mar 01, 2021 8:24AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Why ?
Piter Max
Piter Max Mar 01, 2021 8:09AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
9 Today
Brijesh Patel
Brijesh Patel Mar 01, 2021 7:20AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
ASLAN Pharmaceuticals (ASLN) , a clinical-stage immunology focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced positive interim unblinded data from the three dose cohorts of its ongoing randomised, double-blind placebo controlled multiple ascending dose study of ASLAN004 for the treatment of moderate to severe atopic dermatitis (AD). ASLAN004 was shown to be well tolerated across all doses and showed improvements compared to placebo in all efficacy endpoints, supporting its potential as a differentiated, novel treatment for AD.
Piter Max
Piter Max Feb 25, 2021 8:52AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Great news!!!! 🥳🥳🥳
Piter Max
Piter Max Feb 01, 2021 10:38AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
All the way to FDA approval
Phil La
CallBandit Dec 09, 2020 3:22PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Its going to run here!
Mick West
googleMickWest Oct 16, 2020 8:40AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
SGBX or HTZ what do you guys think?
Ezzeldine Ahmed
Ezzeldine Ahmed Oct 16, 2020 8:40AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
htz
Mick West
googleMickWest Oct 16, 2020 8:36AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
we had several .50 cent bumps 30 min ago. If this thing does bump back up it could go quick.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email